Balancing Cancer Immunotherapy Efficacy and Toxicity

Anti–programmed cell death-1 receptor/programmed cell death-1 receptor ligand–directed therapies are transforming cancer care, with durable antitumor responses observed in multiple cancer types. Toxicities arising from therapy are autoimmune in nature and may affect essentially any organ system. The...

Cijeli opis

Bibliografski detalji
Glavni autori: Johnson, Douglas B., Jakubovic, Baruch D., Sibaud, Vincent, Sise, Meghan E.
Format: Online Članak Tekst
Jezik:English
Izdano: American Academy of Allergy, Asthma & Immunology 2020
Teme:
Review and Feature Article
Online pristup:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Slična djela